Ophthalmic Pharmacology Practice Questions

Q: What is the concentration of xylocaine used for tonometry?

4% xylocaine. **Explanation:** In ophthalmic practice, **4% Xylocaine (Lidocaine)** is the standard concentration used for rapid surface anesthesia. For procedures like **Goldmann Applanation Tonometry (GAT)**, which requires direct contact with the cornea, a potent and fast-acting anesthetic is necessary to abolish the blink reflex and eliminate pain. * **Why 4% is correct:** While lower concentrations (1-2%) are effective for infiltration or nerve blocks, the corneal epithelium acts as a significant barrier. A higher concentration of **4%** ensures rapid penetration and a deep enough level of topical anesthesia (usually within 30–60 seconds) to allow the tonometer prism to touch the cornea without discomfort. It is frequently used in combination with **fluorescein dye** (either as a premixed solution or separately) to visualize the mires during tonometry. * **Why other options are incorrect:** * **1% and 2% Xylocaine:** These concentrations are primarily used for **local infiltration** (e.g., lid surgery) or **regional nerve blocks** (e.g., Peribulbar or Retrobulbar anesthesia). They are generally too weak for effective, rapid-onset topical corneal anesthesia. * **3% Xylocaine:** This is not a standard commercial preparation used in routine ophthalmic practice. **Clinical Pearls for NEET-PG:** 1. **Other Topical Anesthetics:** Proparacaine (0.5%) and Tetracaine (0.5%) are also commonly used for tonometry; Proparacaine is often preferred as it causes less stinging than Xylocaine. 2. **Toxicity:** Repeated use of topical anesthetics is **contraindicated** as it causes "corneal melting" (toxic epithelial keratopathy) and inhibits epithelial healing. 3. **Gold Standard:** Goldmann Applanation Tonometry remains the gold standard for measuring Intraocular Pressure (IOP).

Q: All of the following drugs can cause anterior uveitis except?

Chloroquine. **Explanation:** The correct answer is **Chloroquine**. In ophthalmic pharmacology, understanding drug-induced uveitis is crucial for NEET-PG. **Why Chloroquine is the correct answer:** Chloroquine (and Hydroxychloroquine) is primarily known for causing **retinal toxicity**, specifically "Bull’s eye maculopathy," due to its affinity for melanin in the Retinal Pigment Epithelium (RPE). It does **not** typically cause anterior uveitis. Its anterior segment side effect is limited to **Vortex Keratopathy** (Cornea Verticillata), which is characterized by fine, whorl-like epithelial deposits. **Analysis of other options:** * **Metoprolol:** While rare, systemic Beta-blockers (and more commonly, topical ones like Timolol) have been associated with drug-induced uveitis through immune-mediated mechanisms. * **Brimonidine:** This Alpha-2 agonist is a well-known cause of **granulomatous anterior uveitis**, often occurring months after starting the medication. It is frequently associated with follicular conjunctivitis. * **Cidofovir:** This antiviral (used for CMV retinitis) is a classic cause of severe **fibrinous anterior uveitis** and hypotony. It is often co-administered with oral Probenecid to reduce this risk. **High-Yield Clinical Pearls for NEET-PG:** * **Common drugs causing Anterior Uveitis:** Cidofovir, Rifabutin (classic triad: fever, arthralgia, uveitis), Brimonidine, Bisphosphonates (Zoledronate), and Sulfonamides. * **Vortex Keratopathy Mnemonic (CHAI-T):** **C**hloroquine, **H**ydroxychloroquine, **A**miodarone, **I**ndomethacin, **T**amoxifen (and Fabry’s disease). * **Brimonidine** is contraindicated in children under 2 years due to the risk of CNS depression and apnea.

Q: Which anti-glaucoma drug can induce pigmentation of the iris?

Latanoprost. **Explanation:** **Latanoprost** is the correct answer. It belongs to the **Prostaglandin Analogues (PGAs)** class, which are first-line agents in the management of Primary Open-Angle Glaucoma (POAG). **Mechanism of Pigmentation:** Latanoprost induces iris pigmentation by increasing the **melanin content** within the stromal melanocytes of the iris. It is important to note that it does not cause melanocyte proliferation (hyperplasia); rather, it stimulates **melanogenesis**. This effect is most common in individuals with multi-colored irides (e.g., hazel or blue-brown eyes) and is usually permanent. **Analysis of Incorrect Options:** * **A. Timolol:** A non-selective beta-blocker. Its primary side effects are systemic (bradycardia, bronchospasm) and local (stinging, dry eye), but it does not affect iris color. * **B. Prednisolone:** A corticosteroid. While it can cause a secondary rise in intraocular pressure (steroid-induced glaucoma) and posterior subcapsular cataracts, it does not cause iris pigmentation. * **D. Olopatadine:** An antihistamine/mast cell stabilizer used for allergic conjunctivitis. It has no role in glaucoma management or iris color changes. **High-Yield Clinical Pearls for NEET-PG:** * **Other PGA Side Effects:** Hypertrichosis (increased eyelash growth), darkening of eyelashes, deepening of the upper eyelid sulcus (prostaglandin-associated periorbitopathy), and reactivation of Herpetic keratitis. * **Mechanism of Action:** PGAs lower IOP by increasing **uveoscleral outflow**. * **Contraindication:** Relative contraindication in inflammatory glaucoma (uveitic glaucoma) and cystoid macular edema (CME).

Q: Which of the following is NOT a side effect of apraclonidine?

Watering of mouth. **Explanation:** **Apraclonidine** is a selective alpha-2 adrenergic agonist used primarily to prevent or treat post-laser intraocular pressure (IOP) spikes. **Why "Watering of mouth" is the correct answer:** Apraclonidine, like its relative Brimonidine, is a sympathomimetic. A common systemic side effect of alpha-2 agonists is **Xerostomia (dryness of mouth)**, not watering. This occurs due to the activation of alpha-2 receptors in the salivary glands and the central nervous system, which inhibits salivary secretion. **Analysis of incorrect options:** * **Lid dermatitis & Follicular conjunctivitis:** These are common **local allergic reactions** associated with long-term use of topical alpha-agonists. Apraclonidine has a high rate of delayed hypersensitivity (up to 30-40%), which often manifests as blepharoconjunctivitis. * **Eyelid retraction:** This is a unique side effect of Apraclonidine. It occurs because the drug stimulates the alpha-adrenergic receptors of **Müller’s muscle** (a smooth muscle in the upper eyelid), leading to its contraction and subsequent lid elevation. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Reduces IOP by decreasing aqueous humor production and increasing uveoscleral outflow. * **Tachyphylaxis:** Apraclonidine is notorious for losing its efficacy over time (tachyphylaxis), making it unsuitable for long-term chronic glaucoma management. * **Clinical Use:** It is the drug of choice for preventing IOP spikes after **Nd:YAG laser capsulotomy** or **Laser Peripheral Iridotomy (LPI)**. * **Diagnostic Use:** It is used in the diagnosis of **Horner’s Syndrome**; it causes pupillary dilation in the affected eye (due to denervation supersensitivity) while having no effect on a normal pupil.

Q: Which of the following side effects is associated with the use of systemic corticosteroids?

Cataract. **Explanation:** The correct answer is **B. Cataract**. Systemic corticosteroids are well-known to cause ocular complications, the most characteristic being **Posterior Subcapsular Cataract (PSC)**. The mechanism involves the binding of corticosteroids to lens proteins, leading to protein aggregation and the disruption of lens fiber clarity. While both topical and systemic steroids can cause cataracts, PSC is specifically associated with prolonged systemic use. **Analysis of Options:** * **A. Glaucoma:** While corticosteroids can indeed cause "Steroid-Induced Glaucoma" (due to increased resistance to aqueous outflow at the trabecular meshwork), this side effect is significantly more common with **topical** (drops/ointments) or periocular administration rather than systemic use. In the context of systemic therapy, the risk of cataract is clinically more prevalent and characteristic. * **C. Blepharoconjunctivitis:** This is an inflammatory condition of the eyelids and conjunctiva. Corticosteroids are actually used to *treat* various forms of allergic or non-infectious conjunctivitis; they do not cause it. * **D. None of the above:** Incorrect, as Cataract is a definitive side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Cataract Type:** Steroid-induced cataracts are typically **Posterior Subcapsular (PSC)**. They often cause significant glare and difficulty reading in bright light. * **Steroid Responders:** Approximately 5-10% of the population are "high responders" who develop a significant rise in Intraocular Pressure (IOP) when using steroids. * **Systemic vs. Topical:** Systemic steroids are more likely to cause **Cataracts**, whereas topical steroids are more likely to cause **Glaucoma**. * **Other Systemic Steroid Ocular Effects:** Central Serous Chorioretinopathy (CSCR) and delayed wound healing.

Q: Which of the following drugs can lead to Cystoid Macular Edema?

Latanoprost. **Explanation:** **Cystoid Macular Edema (CME)** is a condition characterized by the accumulation of fluid in the Henle’s layer of the macula, often presenting as a "flower-petal" pattern on Fundus Fluorescein Angiography (FFA). **Why Latanoprost is correct:** Latanoprost is a **Prostaglandin Analogue (PGA)**. PGAs are known to increase the levels of endogenous prostaglandins, which can lead to a breakdown of the blood-aqueous barrier and the blood-retinal barrier. This increased permeability results in fluid leakage into the macula. This side effect is most commonly observed in **aphakic** or **pseudophakic** patients (especially those with a posterior capsular rent). **Analysis of Incorrect Options:** * **Dipevefrine:** This is a prodrug of epinephrine. While epinephrine is classically associated with CME in aphakic eyes (Irvine-Gass Syndrome), Dipevefrine is less commonly implicated in modern clinical practice compared to PGAs. * **Timolol:** A non-selective beta-blocker. Its primary side effects are systemic (bradycardia, bronchospasm) and local (dry eye, stinging); it does not cause CME. * **Brinzolamide:** A topical Carbonic Anhydrase Inhibitor (CAI). Interestingly, CAIs (like Acetazolamide) are actually used to **treat** certain types of macular edema by enhancing the pumping function of the Retinal Pigment Epithelium (RPE). **High-Yield Clinical Pearls for NEET-PG:** * **Drug-induced CME Mnemonic (L-A-D-E-N):** **L**atanoprost, **A**drenaline (Epinephrine), **D**ipivefrin, **E**zetimibe, **N**iacin (Nicotinic acid). * **Docetaxel** (Taxanes) can also cause a unique form of CME without leakage on FFA. * **Gold Standard Investigation:** Optical Coherence Tomography (OCT) is the investigation of choice, showing cystic spaces in the macula.

Q: Chronic use of systemic steroids most commonly leads to which ocular complication?

Cataract. **Explanation:** **Correct Answer: A. Cataract** Systemic steroid therapy (oral or injectable) is most strongly associated with the development of **Posterior Subcapsular Cataract (PSC)**. The underlying mechanism involves the binding of steroids to lens crystallin proteins, leading to protein aggregation and the disruption of lens fiber clarity. While both systemic and topical steroids can cause cataracts, systemic administration carries a higher relative risk for PSC compared to other ocular complications. **Analysis of Incorrect Options:** * **B. Glaucoma:** While steroids can cause "steroid-induced glaucoma" by increasing resistance to aqueous outflow at the trabecular meshwork, this is significantly **more common with topical (drops/ointments)** or periocular administration than with systemic use. * **C. Uveitis:** Steroids are actually the primary treatment for uveitis due to their potent anti-inflammatory properties; they do not cause it. * **D. Conjunctival and lid papillomatosis:** This is not a recognized side effect of steroid therapy. Steroids are more likely to cause thinning of the skin (atrophy) or secondary infections (fungal/viral) due to local immunosuppression. **High-Yield Clinical Pearls for NEET-PG:** * **Cataract Type:** Steroid-induced cataracts are typically **bilateral** and **Posterior Subcapsular**. * **Glaucoma Risk:** The "Steroid Responder" phenomenon (increased IOP) is most prevalent with topical **Dexamethasone** and least with **Fluorometholone** or **Loteprednol**. * **Other Systemic Side Effects:** Long-term use can also lead to Central Serous Chorioretinopathy (CSCR) and delayed wound healing. * **Pediatric Note:** Children are more susceptible to rapid steroid-induced IOP spikes than adults.

Q: Bevacizumab is used in which of the following conditions?

Diabetic retinopathy. **Explanation:** **Bevacizumab** (Avastin) is a recombinant humanized monoclonal antibody that binds to and inhibits **Vascular Endothelial Growth Factor (VEGF)**. In the context of Ophthalmology, it is used off-label as an intravitreal injection to treat vasoproliferative retinal diseases. **Why Diabetic Retinopathy is Correct:** In **Diabetic Retinopathy (DR)**, chronic hyperglycemia leads to retinal ischemia, which triggers the release of VEGF. This results in two major complications: **Diabetic Macular Edema (DME)** (increased vascular permeability) and **Proliferative Diabetic Retinopathy (PDR)** (neovascularization). By neutralizing VEGF, Bevacizumab reduces macular swelling and causes regression of fragile new blood vessels, preventing vitreous hemorrhage and tractional retinal detachment. **Why Other Options are Incorrect:** * **Glaucoma:** While anti-VEGFs are used in *Neovascular Glaucoma* to shrink iris vessels, they are not a treatment for primary open-angle or closed-angle glaucoma. * **Diabetic Nephropathy & Neuropathy:** These are microvascular complications of diabetes, but Bevacizumab is not used to treat them. Nephropathy involves basement membrane thickening and podocyte loss, while neuropathy involves nerve ischemia; neither is currently managed with VEGF inhibitors. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** VEGF-A inhibitor. * **Other Ocular Indications:** Wet Age-Related Macular Degeneration (ARMD), Central Retinal Vein Occlusion (CRVO), and Retinopathy of Prematurity (ROP). * **Comparison:** Unlike **Ranibizumab** (Fab fragment) and **Aflibercept** (decoy receptor), Bevacizumab is a full-length antibody and is significantly more cost-effective for clinical use. * **Side Effects:** Endophthalmitis (most serious post-injection complication) and transient rise in intraocular pressure.

Q: Which of the following anti-glaucoma drugs can likely cause black pigmentation on the conjunctiva?

Adrenaline. **Explanation:** **Correct Option: A (Adrenaline)** Adrenaline (Epinephrine) and its prodrug Dipivefrine are sympathomimetic agents that can cause **adrenochrome deposits** in the conjunctiva. These are small, discrete, black or dark-brown pigment spots. They occur due to the oxidation of adrenaline into melanin-like pigments, which get trapped in the conjunctival stroma or within small cysts. This is a classic high-yield side effect associated with long-term topical adrenaline use. **Incorrect Options:** * **B. Latanoprost:** While Prostaglandin analogues (PGAs) cause pigmentation, they typically cause **iris heterochromia** (darkening of the iris) and **eyelash darkening/thickening**, rather than discrete black conjunctival deposits. * **C. Beta blockers (e.g., Timolol):** These are the most common first-line drugs but are not associated with pigmentation. Their primary side effects are systemic (bradycardia, bronchospasm) and local (dry eye). * **D. Pilocarpine:** A miotic agent that causes side effects like miosis, brow ache, and "ciliary spasm." It does not cause conjunctival pigmentation. **High-Yield Clinical Pearls for NEET-PG:** 1. **Adrenochrome deposits:** Always associate "black spots on conjunctiva" with Adrenaline. 2. **Iris Pigmentation:** Prostaglandin analogues (Latanoprost) increase melanin synthesis in melanocytes (without increasing the number of melanocytes). 3. **Cystoid Macular Edema (CME):** Adrenaline is contraindicated in **aphakic patients** because it can precipitate CME. 4. **Bitot’s Spots vs. Adrenochrome:** Do not confuse these; Bitot’s spots are white/foamy (Vitamin A deficiency), while adrenochrome deposits are black/pigmented.

Q: Which antifungal agent is administered intravitreally for ocular infections?

Amphotericin B. **Explanation:** **Amphotericin B** is the gold standard for the intravitreal treatment of fungal endophthalmitis, particularly when caused by *Aspergillus* or *Candida* species. In cases of exogenous or endogenous endophthalmitis where the infection has breached the blood-retinal barrier or is introduced directly into the vitreous, systemic antifungals often fail to reach therapeutic concentrations. Intravitreal injection (standard dose: **5–10 µg in 0.1 mL**) ensures immediate, high-level bioavailability at the site of infection. **Analysis of Options:** * **Amphotericin B (Correct):** A polyene antifungal that binds to ergosterol in the fungal cell membrane. It is the preferred intravitreal agent due to its broad spectrum and established safety profile at low doses. * **Fluconazole:** While it has excellent ocular penetration when taken **systemically** (oral/IV), it is rarely used intravitreally because its spectrum is limited primarily to *Candida* and it lacks activity against filamentous fungi like *Aspergillus*. * **Itraconazole:** This is highly lipophilic with poor intraocular penetration. It is not formulated for intravitreal use due to solubility issues and potential retinal toxicity. * **Flucytosine:** Primarily used as an oral adjunct therapy. It is never used as monotherapy or as a primary intravitreal agent due to the rapid development of resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Voriconazole (100 µg/0.1 mL):** This is the other major antifungal used intravitreally, often preferred over Amphotericin B for *Aspergillus* due to lower retinal toxicity. * **Natamycin (5%):** The drug of choice for **fungal keratitis** (topical), but it is **not** used intravitreally. * **Drug of Choice for Endophthalmitis:** For bacterial cases, the standard intravitreal "cocktail" is **Vancomycin + Ceftazidime**. For fungal cases, it is **Amphotericin B or Voriconazole**.

Question 1

What is the concentration of xylocaine used for tonometry?

Accepted Answer

4% xylocaine

Answer

3% xylocaine

Answer

2% xylocaine

Answer

1% xylocaine

Question 2

All of the following drugs can cause anterior uveitis except?

Accepted Answer

Chloroquine

Answer

Metoprolol

Answer

Brimonidine

Answer

Cidofovir

Question 3

Which anti-glaucoma drug can induce pigmentation of the iris?

Accepted Answer

Latanoprost

Answer

Timolol

Answer

Prednisolone

Answer

Olopatadine

Question 4

Which of the following is NOT a side effect of apraclonidine?

Accepted Answer

Watering of mouth

Answer

Lid dermatitis

Answer

Follicular conjunctivitis

Answer

Eyelid retraction

Question 5

Which of the following side effects is associated with the use of systemic corticosteroids?

Accepted Answer

Cataract

Answer

Glaucoma

Answer

Blepharoconjunctivitis

Answer

None of the above

Question 6

Which of the following drugs can lead to Cystoid Macular Edema?

Accepted Answer

Latanoprost

Answer

Dipevifrine

Answer

Timolol

Answer

Brinzolamide

Question 7

Chronic use of systemic steroids most commonly leads to which ocular complication?

Accepted Answer

Cataract

Answer

Glaucoma

Answer

Uveitis

Answer

Conjunctival and lid papillomatosis

Question 8

Bevacizumab is used in which of the following conditions?

Accepted Answer

Diabetic retinopathy

Answer

Glaucoma

Answer

Diabetic nephropathy

Answer

Neuropathy

Question 9

Which of the following anti-glaucoma drugs can likely cause black pigmentation on the conjunctiva?

Accepted Answer

Adrenaline

Answer

Latanoprost

Answer

Beta blockers

Answer

Pilocarpine

Question 10

Which antifungal agent is administered intravitreally for ocular infections?

Accepted Answer

Amphotericin B

Answer

Fluconazole

Answer

Itraconazole

Answer

Flucytosine

Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?